Cargando…

PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells

BACKGROUND AND AIMS: Colorectal cancer [CRC] is one of the most frequent malignancies, but the molecular mechanisms driving cancer growth are incompletely understood. We characterised the roles of the cytokine IL-9 and Th9 cells in regulating CRC development. METHODS: CRC patient samples and samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerlach, Katharina, Popp, Vanessa, Wirtz, Stefan, Al-Saifi, Ragheed, Gonzalez Acera, Miguel, Atreya, Raja, Dregelies, Theresa, Vieth, Michael, Fichtner-Feigl, Stefan, McKenzie, Andrew N J, Rosenbauer, Frank, Weigmann, Benno, Neurath, Markus F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197880/ https://www.ncbi.nlm.nih.gov/pubmed/35793807 http://dx.doi.org/10.1093/ecco-jcc/jjac097

Ejemplares similares

VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer
por: Waldner, Maximilian J., et al.
Publicado: (2010)

CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental Colitis
por: Kang, Le, et al.
Publicado: (2021)

Detection of Fusobacterium nucleatum in Patients with Colitis-Associated Colorectal Cancer
por: Dregelies, Theresa, et al.
Publicado: (2023)

The transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis
por: Weigmann, Benno, et al.
Publicado: (2008)

Confocal Laser Endomicroscopy for In Vivo Diagnosis of Clostridium difficile Associated Colitis — A Pilot Study
por: Neumann, Helmut, et al.
Publicado: (2013)

Cytokines Mediating the Induction of Chronic Colitis and Colitis-Associated Fibrosis
por: Fichtner-Feigl, Stefan, et al.
Publicado: (2008)

Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation
por: Schulz-Kuhnt, Anja, et al.
Publicado: (2020)

Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases
por: Schulz-Kuhnt, Anja, et al.
Publicado: (2021)

Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time
por: Wirtz, Stefan, et al.
Publicado: (2021)

The Memory T Cell “Communication Web” in Context with Gastrointestinal Disorders—How Memory T Cells Affect Their Surroundings and How They Are Influenced by It
por: Knauss, Annkathrin, et al.
Publicado: (2022)

Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer
por: Kesselring, Rebecca, et al.
Publicado: (2012)

Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis
por: Lechner, Kristina S., et al.
Publicado: (2020)

Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?
por: Abdullah, Abdullah, et al.
Publicado: (2020)

Effect of a Flavonoid Combination of Apigenin and Epigallocatechin-3-Gallate on Alleviating Intestinal Inflammation in Experimental Colitis Models
por: Li, Mingrui, et al.
Publicado: (2023)

Advanced Endoscopic Imaging for Diagnosis of Crohn's Disease
por: Neumann, Helmut, et al.
Publicado: (2012)

Neutrophils prevent rectal bleeding in ulcerative colitis by peptidyl-arginine deiminase-4-dependent immunothrombosis
por: Leppkes, Moritz, et al.
Publicado: (2022)

Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles
por: Fuchs, Friederike, et al.
Publicado: (2017)

Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease
por: Lang-Schwarz, Corinna, et al.
Publicado: (2021)

Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging
por: Kreiss, Lucas, et al.
Publicado: (2022)

STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
por: Pickert, Geethanjali, et al.
Publicado: (2009)

The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis
por: Schmitt, Heike, et al.
Publicado: (2020)

Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
por: Rath, Timo, et al.
Publicado: (2018)

Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis
por: Besendorf, Laura, et al.
Publicado: (2022)

Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis
por: Lindemann, Aylin, et al.
Publicado: (2023)

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma
por: Zundler, Sebastian, et al.
Publicado: (2023)

Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype
por: Gonzalez Acera, Miguel, et al.
Publicado: (2021)

Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies
por: Gabel, Michael, et al.
Publicado: (2022)

Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis
por: Reißig, Sonja, et al.
Publicado: (2017)

Beyond endoscopic assessment in inflammatory bowel disease: real-time histology of disease activity by non-linear multimodal imaging
por: Chernavskaia, Olga, et al.
Publicado: (2016)

Deciphering Novel Mechanistic and Pharmacokinetic Effects of Tofacitinib in Intestinal Inflammation: Expect the Unexpected
por: Atreya, Raja, et al.
Publicado: (2021)

IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
por: Atreya, Raja, et al.
Publicado: (2022)

IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells
por: Ullrich, Karen Anne-Marie, et al.
Publicado: (2023)

Baseline levels of dynamic CD4(+) T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study
por: Allner, Clarissa, et al.
Publicado: (2020)

Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists
por: Lang-Schwarz, Corinna, et al.
Publicado: (2021)

Pu /
por: Ramírez, Armando
Publicado: (2003)

Pu /
por: Ramírez,R. Armando
Publicado: (1977)

Endoscopic Therapy in Inflammatory Bowel Diseases
por: Neumann, Helmut, et al.
Publicado: (2015)

Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
por: Atreya, Raja, et al.
Publicado: (2020)

Role of the IL23/IL17 Pathway in Crohn’s Disease
por: Schmitt, Heike, et al.
Publicado: (2021)

Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitis
por: Zeeshan, Mahira, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_62c0gudljfnanroc86goikgtqr